InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (54 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
54
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by SVF Endurance (Cayman) Ltd. Director active across 1 company, notably Vir Biotechnology, Inc.. Aggregated, 54 reports have been recorded. Breakdown: 0 buy · 54 sells. Total volume traded: €68.2m. History available since 20 December 2021. The latest transaction was filed on 28 October 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations54 total
24,453 shares@ US$6.5025Common StockSEC:0001493152-25-020240:0
46,696 shares@ US$5.9595Common StockSEC:0001493152-25-019892:0
144,266 shares@ US$6.1529Common StockSEC:0001493152-25-019309:0
220,535 shares@ US$6.1998Common StockSEC:0001493152-25-018917:0
16,671 shares@ US$6.07020.1% of flowCommon StockSEC:0001493152-25-018462:0
249,060 shares@ US$6.14282.0% of flowCommon StockSEC:0001493152-25-018021:0
72,133 shares@ US$5.60290.5% of flowCommon StockSEC:0001493152-25-017612:0
450,342 shares@ US$5.55533.3% of flowCommon StockSEC:0001493152-25-017300:0
700 shares@ US$25.110.0% of flowCommon StockSEC:0000899243-23-017010:0
7,010 shares@ US$25.09580.2% of flowCommon StockSEC:0000899243-23-016775:0
9,902 shares@ US$25.17690.3% of flowCommon StockSEC:0000899243-23-016308:0
52,765 shares@ US$25.84651.5% of flowCommon StockSEC:0000899243-23-016075:0
36,547 shares@ US$26.80581.1% of flowCommon StockSEC:0000899243-23-015663:0
34,365 shares@ US$27.31651.1% of flowCommon StockSEC:0000899243-23-014628:0
2,317 shares@ US$25.83850.1% of flowCommon StockSEC:0000899243-23-013936:0
91,651 shares@ US$25.38142.7% of flowCommon StockSEC:0000899243-23-013759:0
136 shares@ US$25.10320.0% of flowCommon StockSEC:0000899243-23-012478:0
83,674 shares@ US$25.5122.4% of flowCommon StockSEC:0000899243-23-012410:0
3,075 shares@ US$25.30470.1% of flowCommon StockSEC:0000899243-23-012176:0
66,038 shares@ US$25.41921.9% of flowCommon StockSEC:0000899243-23-011791:0
6,590 shares@ US$25.06030.2% of flowCommon StockSEC:0000899243-23-011617:0
6,953 shares@ US$25.12030.2% of flowCommon StockSEC:0000899243-23-011512:0
9,565 shares@ US$25.10740.3% of flowCommon StockSEC:0000899243-23-011414:0
242 shares@ US$26.950.0% of flowCommon StockSEC:0000899243-23-006057:0
38,964 shares@ US$26.75251.2% of flowCommon StockSEC:0000899243-23-005577:0
25 of 54 declarations
About SVF Endurance (Cayman) Ltd
Public sources show that SVF Endurance (Cayman) Ltd is a reporting shareholder tied to Vir Biotechnology, Inc., appearing in SEC filings as part of a reporting group with SB Investment Advisers (UK) Limited and SoftBank Vision Fund (AIV M1) L.P. An SEC filing states that SVF Endurance (Cayman) Ltd held 13,116,977 shares of Vir Biotechnology common stock in the 2026 Schedule 13G filing. Company filings also describe SVF Endurance (Cayman) Ltd as a SoftBank-affiliated entity with an address in the Cayman Islands. Sources : https://www.sec.gov/Archives/edgar/data/1731509/000149315226007174/xslSCHEDULE_13G_X01/primary_doc.xml
